PTGS2 and polycystic ovary syndrome: Yu et al found that PTGS2 expression was increased in PCOS mice and was significantly decreased by treatment with β-sitosterol.[39] Further in vitro and in vivo experiments are required to verify whether MT can improve PCOS symptoms by targeting PTGS2.